Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D
Clinical trial NCT06829563 · RECRUITING
Trial details
- NCT number
- NCT06829563
- Sponsor
- Rezubio Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2025-12-20
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.